{
  "report_rows": [
    {
      "kpi": "Non-GAAP EPS (Q4 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$2.95 vs. cons ~$2.90",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (Q4 FY26)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.47B vs. cons ~$1.46B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP gross margin (Q4 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~63.1% vs. cons ~62.8%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY27 revenue growth framework",
      "prediction": "UNCHANGED",
      "answer": "guide ~high-single-digit / ~+8% vs. cons ~+8% (FY27)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY27 gross margin trajectory",
      "prediction": "BETTER",
      "answer": "guide ~63%+ (continued annual expansion) vs. cons ~63.0% (FY27)",
      "confidence": "LOW"
    },
    {
      "kpi": "U.S./Americas device growth (Q4)",
      "prediction": "UNKNOWN",
      "answer": "pred ~6-7% vs. cons ~6% (Q4 FY26)",
      "confidence": "LOW"
    },
    {
      "kpi": "Quarterly dividend",
      "prediction": "BETTER",
      "answer": "guide ~$0.68 (raise ~13%) vs. cons ~$0.60 (FY27 Q1)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.0,
  "day5_path": "FADE",
  "day5_rationale": "Likely modest EPS/margin beat plus reassuring GLP-1 real-world data drives an initial pop, but the stock already rallied ~16% in two weeks into the print (from ~$192 to $224), re-inflating expectations. FY27 framing at high-single-digit revenue growth (EPS outpacing) caps out-period upside revisions rather than lifting them meaningfully, and lingering GLP-1/Philips overhang plus the CFO transition limit multiple expansion, so the day-1 gain partly fades over the week.",
  "day5_confidence": "LOW"
}